Results 1 to 10 of about 601,516 (329)

Inclisiran, Low-Density Lipoprotein Cholesterol and Lipoprotein (a)

open access: yesPharmaceuticals, 2023
Dyslipidemia treatment is of major importance in reducing the risk of atherosclerotic cardiovascular disease (ASCVD), which is still the most common cause of death worldwide. During the last decade, a novel lipid-lowering drug category has emerged, i.e.,
Niki Katsiki   +3 more
doaj   +4 more sources

Physiological Bases for the Superiority of Apolipoprotein B Over Low‐Density Lipoprotein Cholesterol and Non–High‐Density Lipoprotein Cholesterol as a Marker of Cardiovascular Risk

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2022
In 2019, the European Society of Cardiology/European Atherosclerosis Society stated that apolipoprotein B (apoB) was a more accurate marker of cardiovascular risk than low‐density lipoprotein cholesterol (LDL‐C) and non–high‐density lipoprotein ...
Tamara Glavinovic   +5 more
doaj   +2 more sources

Oxidized low-density lipoprotein cholesterol and plaque vulnerability [PDF]

open access: yesAmerican Heart Journal Plus
Background: The oxidation of low-density lipoprotein cholesterol (LDL-C) plays a critical role in plaque inflammation and the subsequent high-risk plaque formation.
Jun Goto   +11 more
doaj   +2 more sources

Low density Lipoprotein cholesterol target: Changing goal posts

open access: yesIndian Journal of Endocrinology and Metabolism, 2012
Elevated low density lipoprotein cholesterol (LDL) has been identified as one of the strongest correctable risk factors for cardiovascular disease in patients with diabetes. The reduction in cardiovascular events with pharmacological therapy aimed at LDL
Ganapathi Bantwal, Belinda George
doaj   +3 more sources

The effect of Ramadan fasting on lipid profile in pregnant women [PDF]

open access: yesJournal of Fasting and Health, 2015
Introduction: Abnormal lipid profile causes maternal mortality and impairs fetal development. This study investigated the effect of Ramadan fasting on plasma lipid profile in pregnant women.
Abolfazl Khoshdel   +4 more
doaj   +3 more sources

Association between lipid ratio and depression: a cross-sectional study

open access: yesScientific Reports, 2022
Depression is associated with total cholesterol, low-density lipoprotein cholesterol, triglycerides, and high-density lipoprotein cholesterol levels in the blood.
A Lum Han
doaj   +1 more source

Blood lipid spectrum and elastic properties of arteries in patients with chronic pancreatitis in combination with arterial hypertension

open access: yesMedičnì Perspektivi, 2022
110 patients aged 45-65 years with chronic pancreatitis were examined. The first group consisted of patients with a combined course of chronic pancreatitis with arterial hypertension; the second group - patients with chronic pancreatitis without ...
A.Yu. Filippova   +2 more
doaj   +1 more source

The effect of eight weeks of 30-20-10 interval training on serum spexin levels and lipid profile in obese middle-aged men [PDF]

open access: yesفیزیولوژی ورزش و فعالیت بدنی, 2023
Background and Purpose: The purpose of this study was to investigate the effect of 30-20-10 interval training on the serum spexin level and lipid profile of obese men in order to measure the effect of physical activity on increasing spexin and improving ...
Hamid Yazdanshenas   +2 more
doaj   +1 more source

An integrated mathematical model of cellular cholesterol biosynthesis and lipoprotein metabolism [PDF]

open access: yes, 2018
Cholesterol regulation is an important aspect of human health. In this work we bring together and extend two recent mathematical models describing cholesterol biosynthesis and lipoprotein endocytosis to create an integrated model of lipoprotein ...
Pool, Frances   +2 more
core   +2 more sources

Atorvastatin increases human serum levels of proprotein convertase subtilisin/kexin type 9

open access: yesJournal of Lipid Research, 2008
Proprotein convertase subtilisin/kexin type 9 (PCSK9) has gained attention as a key regulator of serum low density lipoprotein cholesterol (LDL-C) levels. This novel protease causes the degradation of hepatic low density lipoprotein receptors. In humans,
Holly E. Careskey   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy